SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-21-012167
Filing Date
2021-05-14
Accepted
2021-05-13 20:55:44
Documents
61
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q kmph20210331_10q.htm 10-Q 1512943
2 EXHIBIT 31.1 ex_241413.htm EX-31.1 14660
3 EXHIBIT 31.2 ex_241414.htm EX-31.2 14743
4 EXHIBIT 32.1 ex_241415.htm EX-32.1 7093
5 EXHIBIT 32.2 ex_241416.htm EX-32.2 7365
  Complete submission text file 0001437749-21-012167.txt   6434783

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT kmph-20210331.xml EX-101.INS 1188996
7 XBRL TAXONOMY EXTENSION SCHEMA kmph-20210331.xsd EX-101.SCH 67343
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kmph-20210331_cal.xml EX-101.CAL 42810
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kmph-20210331_def.xml EX-101.DEF 452737
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE kmph-20210331_lab.xml EX-101.LAB 383992
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kmph-20210331_pre.xml EX-101.PRE 468889
Mailing Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747
Business Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747 (321) 939-3416
KEMPHARM, INC (Filer) CIK: 0001434647 (see all company filings)

IRS No.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36913 | Film No.: 21921604
SIC: 2834 Pharmaceutical Preparations